Newsfile Corp
10 Nov 2025, 23:44 UTC · 44w ago
Verdict
Headline takes no side. We score MLTX −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 96% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
MoonLake's Phase 3 VELA program results showed that SLK failed to demonstrate competitive efficacy relative to BIMZELX.
So whatFailure of a Phase 3 trial for a lead asset typically destroys the primary valuation thesis for a biotech company.
More negative than 99% of claims this week
MoonLake's stock price fell 89.9% to $6.24 on September 29, 2025, following the trial results announcement.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 98% of claims this week
A federal securities class action lawsuit has been filed alleging MoonLake made false or misleading statements regarding SLK's superiority to monoclonal antibodies.
More negative than 82% of claims this week
Which stocks this story touches
More negative than 96% of ticker scores this week
The company is facing a federal securities class action lawsuit following a 89.9% stock price crash due to failed Phase 3 clinical trial results.
More negative than 82% of ticker scores this week
The company is mentioned in the context of a securities class action lawsuit deadline.
More negative than 82% of ticker scores this week
The company is mentioned in the context of a securities class action lawsuit deadline.
More negative than 82% of ticker scores this week
The company is mentioned in the context of a securities class action lawsuit deadline.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
2d ago
+14.5%
Price is moving against the score
$12.39 vs $10.82 close before publication (Nov 10) · not market-adjusted
MLTX chart →
